A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins
NCT01350141
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
46
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypercholesterolemia
Dyslipidemia
Interventions
OTHER:
Placebo
DRUG:
PF-04950615 (RN316)
DRUG:
PF-04950615 (RN316)
Sponsor
Pfizer